Compare AU
Compare ATOM vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X Uranium ETF (ATOM) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
ATOM | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 30 | 241 |
Median incremental investment | $997.50 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,327.04 | $1,668.00 |
Average age group | > 35 | 26 - 35 |
Key Summary
ATOM | IXJ | |
|---|---|---|
Strategy | ATOM.AX was created on 2022-12-07 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Global Uranium & Nuclear Components Total Return Index | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | Cameco Corp (26.59 %) Sprott Physical Uranium Trust Units (8.22 %) NexGen Energy Ltd (7.43 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Energy (72.09 %) Financials (12.54 %) Other (6.93 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | Canada (47.95 %) United States (17.46 %) Australia (11.43 %) | United States (99.97 %) |
Management fee | 0.69 % | 0.46 % |
Key Summary
ATOM | IXJ | |
|---|---|---|
Issuer | Global X | iShares |
Tracking index | Solactive Global Uranium & Nuclear Components Index | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.69 % | 0.46 % |
Price | $16.16 | $139.00 |
Size | $45.107 million | $1.414 billion |
10Y return | N/A | 126.37 % |
Annual distribution yield (5Y) | 0.46 % | 1.26 % |
Market | ASX | ASX |
First listed date | 06/12/2022 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
ATOM | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 30 | 241 |
Median incremental investment | $997.50 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,327.04 | $1,668.00 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
ATOM | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
ATOM | IXJ |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |